financetom
News
World
Environment
Technology
Politics
Retail
Business
Economy
Market summary >
Editors' picks >
News >
World >
Market >
Environment >
Technology >
Factbox-Top cases now before the US Supreme Court
Factbox-Top cases now before the US Supreme Court
Jan 16, 2025
(Reuters) -The U.S. Supreme Court's current term includes cases involving TikTok, guns, gender-affirming medical care for transgender minors, online pornography, religious rights, preventive healthcare, Planned Parenthood funding, job discrimination, federal regulatory powers on nuclear waste storage and vape products, voting rights and more. Here is a look at some of the cases before the justices. U.S. TIKTOK BAN The justices...
Demystifying Churchill Downs: Insights From 4 Analyst Reviews
Demystifying Churchill Downs: Insights From 4 Analyst Reviews
Jan 16, 2025
Analysts' ratings for Churchill Downs over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...
A Glimpse Into The Expert Outlook On Wolfspeed Through 8 Analysts
A Glimpse Into The Expert Outlook On Wolfspeed Through 8 Analysts
Jan 16, 2025
Throughout the last three months, 8 analysts have evaluated Wolfspeed ( WOLF ) , offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 1 2 1...
FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate
FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate
Jan 16, 2025
The Director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) issued a notice summarizing the grounds for refusing a new drug application (NDA) submitted by Vanda Pharmaceuticals, Inc ( VNDA ). for Tradipitant for symptoms in gastroparesis. The notice offers Vanda an opportunity to request a hearing on the matter. Also...
Personal Finance >
Politics >
Retail >
Business >
Two Global Leaders in Eyesight Restoration, Advancing Sight Network and Miracles In Sight, Announce Merger
Two Global Leaders in Eyesight Restoration, Advancing Sight Network and Miracles In Sight, Announce Merger
Nov 6, 2025
With an unwavering commitment to the mission of restoring sight, the two nonprofits – with more than 125 years of service collectively – will begin operating as one organization in January 2026 The new organization will build on the knowledge, success, and expertise of both nonprofits in order to leverage their collective experience to maximize impact for donors, donor...
Form 8.3
Form 8.3
Nov 6, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Canada's Budget Offers Buying Opportunity for US Dollar-Canadian Dollar Cross, Says UBS
Canada's Budget Offers Buying Opportunity for US Dollar-Canadian Dollar Cross, Says UBS
Nov 6, 2025
09:12 AM EST, 11/06/2025 (MT Newswires) -- This week saw the release of the Canadian federal budget, which came broadly in line with market estimates, triggering little initial market reaction, said UBS. While on paper this supports USD/CAD's current low volatility regime, the bank sees this as a buying opportunity. In contrast to EUR/USD volatility, USD/CAD implied volatility is already...
Enovis' Fiscal Q3 Adjusted Earnings, Net Sales Rise; 2025 Guidance Revised
Enovis' Fiscal Q3 Adjusted Earnings, Net Sales Rise; 2025 Guidance Revised
Nov 6, 2025
09:12 AM EST, 11/06/2025 (MT Newswires) -- Enovis ( ENOV ) reported fiscal Q3 adjusted earnings Thursday of $0.75 per diluted share, up from $0.73 a year earlier. Analysts polled by FactSet expected $0.65. Net sales for the quarter ended Oct. 3 were $548.9 million, up from $505.2 million a year earlier. Analysts surveyed by FactSet expected $538.6 million. For...
Economy >
Cryptocurrency >
Forex >
Copyright 2023-2026 - www.financetom.com All Rights Reserved